EUVIMEDEUVIMED entdecken
Crossref

Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUN

Jerry Li, Sarita Pandit, Kanakaraju Manupati, Andrew Wang, Shadid U Zaman, Yana Cen

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026

DOI: 10.1016/j.bbadis.2026.168280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026. Verfasst von Jerry Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Todd Allen Phillips Center for Medical Sciences, Mills E. Godwin High School, Glen Allen, VA, 23238-0540, United States. Hauptthemen laut MEDLINE: Curcumin, Proto-Oncogene Proteins c-fos, Head and Neck Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural products and affordable herbal medications have emerged as promising alternatives for cancer therapy, particularly for patients with limited access to standard treatments. Among these, curcumin, the bioactive polyphenol from Curcuma longa (turmeric), has shown broad anti-cancer potential. However, its molecular mechanism remains poorly defined, especially for head and neck squamous cell carcinoma (HNSCC). Here, we identify curcumin as a potent inhibitor of HNSCC tumorigenesis and explored its underlying mechanism. Comparative analyses of three anti-cancer natural products, including curcumin, gingerol, and allicin, revealed that only curcumin robustly inhibited HNSCC cell proliferation, invasion, and cancer stem cell self-renewal, with potency comparable or superior to cisplatin. Transcriptomic and Gene Set Enrichment Analyses demonstrated that curcumin significantly suppressed FOSL1/AP-1 signaling, a well-known key oncogenic signaling that promotes malignant progression of HNSCC. Biophysical and biochemical assays showed that curcumin directly binds to the FOSL1/JUN heterodimer (Kd ≈ 10 μM), disrupting its DNA-binding activity. In agree with this finding, chromatin immunoprecipitation confirmed that curcumin inhibited FOSL1/JUN recruitment to promoter of cancer stem cell marker gene BMI1, as well as super-enhancer-associated oncogenic loci such as MET, EGFR and TP63. At last, curcumin treatment profoundly suppressed HNSCC tumor growth in xenograft model and exhibited superior efficacy compared with the FOSL1/AP-1 inhibitor T-5224, without apparent toxicity. Collectively, our findings identify FOSL1/JUN complex as a direct molecular target of curcumin and uncover a novel mechanism by which this accessible natural product suppresses HNSCC tumorigenesis, supporting its potential as an affordable and safe therapeutic option for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminProto-Oncogene Proteins c-fosHead and Neck NeoplasmsCarcinogenesisProto-Oncogene Proteins c-junSquamous Cell Carcinoma of Head and NeckHumansFos-Related Antigen 1AnimalsCell Line, TumorMiceCell ProliferationGene Expression Regulation, NeoplasticSignal TransductionXenograft Model Antitumor AssaysMice, NudeNeoplastic Stem Cells

Stichwörter der Autor:innen

CurcuminHNSCCInhibitorSuper-enhancerTumorigenesis

Substanzen

CurcuminFos-Related Antigen 1Proto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junJUN protein, human

Autor:innen und Institutionen

  • Todd Allen Phillips Center for Medical Sciences, Mills E. Godwin High School, Glen Allen, VA, 23238-0540, United States.
  • Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298-0540, United States.
  • Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298-0540, United States; College of Arts and Sciences, The College of William & Mary, Williamsburg, VA, 23187-8795…
  • Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298-0540, United States. Electronic address: zamans@vcu.edu.
  • Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298-0540, United States. Electronic address: ceny2@vcu.edu.

Zitieren

APA

Li, J., Pandit, S., Manupati, K., Wang, A., Zaman, S. U., & Cen, Y. (2026). Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUN. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168280

Vancouver

Li J, Pandit S, Manupati K, Wang A, Zaman SU, Cen Y. Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUN. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026. doi:10.1016/j.bbadis.2026.168280

BibTeX
@article{Li2026,
  author = {Li, Jerry and Pandit, Sarita and Manupati, Kanakaraju and Wang, Andrew and Zaman, Shadid U and Cen, Yana},
  title = {Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUN},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2026},
  doi = {10.1016/j.bbadis.2026.168280}
}
Kostenlos starten →